Aspyra Inc. (APYI) Hisse Analizi
Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
$'dan işlem gören Aspyra Inc. (APYI), 0 değerindeki bir Healthcare şirketidir. Hisse senedi, 9 kantitatif KPI'ya dayalı olarak orta dereceli bir derecelendirme olan 52/100 puan alıyor.
Son analiz: 18 Mar 2026Aspyra Inc. (APYI) Sağlık ve Boru Hattı Genel Bakışı
Aspyra Inc. delivers engineered workflow solutions, encompassing software, hardware, and professional services, to the healthcare sector, specifically targeting labs, clinics, and imaging centers. Founded in 1978, the company focuses on providing integrated solutions for laboratory and imaging workflows, operating within a competitive healthcare IT landscape.
Yatırım Tezi
Aspyra Inc. presents a focused play within the healthcare information services sector, offering specialized workflow solutions for labs and imaging centers. While the company's small market capitalization and OTC listing introduce inherent risks, its established presence since 1978 suggests a degree of stability. Key value drivers include the potential for increased adoption of its integrated software and hardware solutions by healthcare providers seeking to improve operational efficiency. However, the company's negative profit margin of -60.9% raises concerns about its financial sustainability. The beta of -51.48 indicates an inverse correlation with the market, which may offer diversification benefits but also reflects potential business-specific risks. Investors should closely monitor Aspyra's ability to achieve profitability and manage its cost structure.
FMP finansallarına ve nicel analizine dayanmaktadır
Temel Önemli Noktalar
- Aspyra Inc. operates in the healthcare information services sector, providing specialized workflow solutions for labs and imaging centers.
- The company was founded in 1978, indicating a long-standing presence in the healthcare IT market.
- Aspyra's solutions include software, interfaces, hardware, and professional services, offering an integrated approach to healthcare workflows.
- The company serves a diverse clientele, including specialty labs, reference labs, clinics, hospitals, imaging centers, and orthopedic practices.
- Aspyra Inc. has a negative profit margin of -60.9%, highlighting the need for improved financial performance.
Rakipler & Benzerleri
Güçlü Yönler
- Long-standing presence in the healthcare IT market.
- Integrated solutions encompassing software, hardware, and services.
- Focus on specialized laboratory and imaging workflows.
- Established customer base across various healthcare settings.
Zayıflıklar
- Negative profit margin indicating financial challenges.
- Small market capitalization and OTC listing posing liquidity risks.
- Limited brand recognition compared to larger competitors.
- Dependence on a niche segment of the healthcare IT market.
Katalizörler
- Upcoming: Potential partnerships with larger healthcare providers to expand market reach.
- Ongoing: Continued development and enhancement of existing software and hardware solutions.
- Ongoing: Efforts to improve operational efficiency and reduce costs.
Riskler
- Potential: Negative profit margin and financial instability.
- Potential: Limited liquidity due to OTC listing.
- Ongoing: Intense competition from larger and more established players.
- Potential: Evolving regulatory requirements and technological advancements.
- Potential: Cybersecurity threats and data privacy concerns.
Büyüme Fırsatları
- Expansion into Telehealth Solutions: Aspyra can leverage its existing expertise in healthcare IT to develop and offer telehealth solutions, capitalizing on the growing demand for remote patient monitoring and virtual consultations. The telehealth market is projected to reach $55.6 billion by 2027, presenting a significant opportunity for Aspyra to diversify its revenue streams and expand its customer base. Timeline: 1-2 years.
- Strategic Partnerships with Healthcare Providers: Aspyra can forge strategic partnerships with hospitals, clinics, and other healthcare providers to integrate its workflow solutions into their existing systems. These partnerships can provide Aspyra with access to a larger customer base and enhance its market visibility. Timeline: Ongoing.
- Development of AI-Powered Diagnostic Tools: Aspyra can invest in the development of artificial intelligence (AI)-powered diagnostic tools to enhance the capabilities of its imaging solutions. AI-powered diagnostics can improve the accuracy and speed of image analysis, leading to better patient outcomes and increased efficiency for healthcare providers. Timeline: 2-3 years.
- Geographic Expansion into Emerging Markets: Aspyra can expand its operations into emerging markets, where there is a growing demand for healthcare IT solutions. These markets offer significant growth potential due to increasing healthcare spending and a lack of established players. Timeline: 3-5 years.
- Focus on Cybersecurity Solutions for Healthcare: With the increasing threat of cyberattacks on healthcare organizations, Aspyra can develop and offer cybersecurity solutions specifically tailored for the healthcare industry. This can help healthcare providers protect sensitive patient data and ensure the integrity of their systems. Timeline: 1-2 years.
Fırsatlar
- Expansion into telehealth solutions.
- Strategic partnerships with healthcare providers.
- Development of AI-powered diagnostic tools.
- Geographic expansion into emerging markets.
Tehditler
- Intense competition from larger and more established players.
- Evolving regulatory requirements and technological advancements.
- Cybersecurity threats and data privacy concerns.
- Economic downturns impacting healthcare spending.
Rekabet Avantajları
- Established presence in the healthcare IT market since 1978.
- Integrated solutions offering a comprehensive approach to healthcare workflows.
- Specialized expertise in laboratory and imaging workflows.
APYI Hakkında
Aspyra Inc., established in 1978 and headquartered in Jacksonville, Florida, operates within the healthcare sector, providing a range of products and services tailored for the laboratory and imaging marketplaces. Originally named Creative Computer Applications Inc., the company rebranded as Aspyra Inc. in 2005 to better reflect its focus on integrated healthcare solutions. Aspyra's core offerings include engineered workflow solutions comprising software, interfaces, hardware, and professional services. These solutions are designed to optimize operations for a diverse clientele, including specialty labs, reference labs, clinics, hospitals, imaging centers, and orthopedic practices. The company's products facilitate efficient data management, streamlined workflows, and enhanced diagnostic capabilities within these healthcare settings. Aspyra's integrated approach aims to improve patient care and operational efficiency for its clients. With a history spanning over four decades, Aspyra has evolved to meet the changing needs of the healthcare industry, focusing on providing comprehensive solutions that address the specific challenges faced by laboratories and imaging centers. The company's commitment to innovation and customer satisfaction has allowed it to maintain a presence in the competitive healthcare IT market.
Ne Yaparlar
- Provides healthcare products and services for the laboratory and imaging marketplaces.
- Offers engineered workflow solutions that include software.
- Provides hardware solutions for labs and imaging centers.
- Offers professional services to support its products.
- Serves specialty labs, reference labs, clinics, and hospitals.
- Caters to imaging centers and orthopedic practices.
İş Modeli
- Sells integrated software and hardware solutions to healthcare providers.
- Generates revenue through professional services, including implementation and support.
- Focuses on recurring revenue through software maintenance and upgrades.
Sektör Bağlamı
Aspyra Inc. operates within the healthcare information services industry, a sector experiencing growth driven by the increasing adoption of digital health solutions and the need for improved efficiency in healthcare workflows. The market is competitive, with established players and emerging startups vying for market share. Aspyra's focus on providing integrated solutions for labs and imaging centers positions it within a niche segment of the broader healthcare IT market. The industry is characterized by evolving regulatory requirements, technological advancements, and a growing emphasis on data security and interoperability.
Kilit Müşteriler
- Specialty labs
- Reference labs
- Hospitals and clinics
- Imaging centers
- Orthopedic practices
Finansallar
Grafik & Bilgi
Aspyra Inc. (APYI) hisse senedi fiyatı: Price data unavailable
Son Haberler
APYI için son haber bulunmamaktadır.
Analist Konsensüsü
Fikir Birliği Derecelendirmesi
APYI için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.
Fiyat Hedefleri
APYI için Wall Street fiyat hedefi analizi.
MoonshotScore
Bu puan ne anlama geliyor?
MoonshotScore, APYI'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.
Yönetim: Gary W. Bennett
CEO
Gary W. Bennett serves as the CEO of Aspyra Inc., leading the company's strategic direction and overseeing its operations. His background includes experience in managing technology-driven businesses and driving growth in the healthcare IT sector. With a focus on innovation and customer satisfaction, Bennett is responsible for guiding Aspyra's efforts to provide integrated workflow solutions for laboratories and imaging centers. His leadership is crucial in navigating the competitive healthcare IT landscape and ensuring the company's long-term success.
Sicil: Under Gary W. Bennett's leadership, Aspyra Inc. has focused on maintaining its position in the healthcare IT market by providing specialized solutions for labs and imaging centers. Key milestones include the continued development and enhancement of the company's software and hardware offerings. His tenure has been marked by efforts to improve operational efficiency and expand the company's customer base.
APYI OTC Piyasa Bilgileri
The OTC Other tier represents the lowest tier of the OTC market, encompassing stocks that may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, and trading activity can be sporadic. Investing in OTC Other stocks carries a higher degree of risk compared to stocks listed on major exchanges like the NYSE or NASDAQ due to the potential for less transparency and regulatory oversight.
- OTC Katmanı: OTC Other
- Açıklama Durumu: Unknown
- Limited financial disclosure and transparency.
- Low trading volume and liquidity.
- Potential for price manipulation and fraud.
- Higher risk of business failure or delisting.
- Limited regulatory oversight and investor protection.
- Verify the company's legal status and registration.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the risks associated with the OTC Other tier.
- Consult with a qualified financial advisor.
- Check for any regulatory actions or legal proceedings.
- Established presence in the healthcare IT market since 1978.
- Focus on providing specialized solutions for labs and imaging centers.
- Existence of a functional website and contact information.
- Leadership team with relevant industry experience.
- Positive customer testimonials or case studies (if available).
Yatırımcılar Aspyra Inc. (APYI) Hakkında Ne Soruyor
APYI için değerlendirilmesi gereken temel faktörler nelerdir?
Aspyra Inc. (APYI) şu anda yapay zeka skoru 52/100, orta puanı gösteriyor. Temel güçlü yan: Long-standing presence in the healthcare IT market.. İzlenmesi gereken birincil risk: Potential: Negative profit margin and financial instability.. Bu bir finansal tavsiye değildir.
APYI MoonshotScore'u nedir?
APYI şu anda MoonshotScore'da 52/100 (Derece C) alıyor, bu da orta derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.
APYI verileri ne sıklıkla güncellenir?
APYI fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.
Analistler APYI hakkında ne diyor?
APYI için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.
APYI'a yatırım yapmanın riskleri nelerdir?
APYI için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Negative profit margin and financial instability.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.
APYI'ın P/E oranı nedir?
APYI için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için APYI'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.
APYI aşırı değerli mi, yoksa düşük değerli mi?
Aspyra Inc. (APYI)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.
APYI'ın temettü verimi nedir?
Aspyra Inc. (APYI) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.
Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.
Resmi Kaynaklar
Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.
- Limited financial information available due to OTC listing.
- AI analysis pending for APYI.